Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Ferric Maltol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 92Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cadila Pharmaceuticals launches iron supplement ‘Militol’
    Cadila Pharmaceuticals launches iron supplement ‘Militol’

    14 Nov 2024

    // EXPRESSPHARMA

    https://www.expresspharma.in/cadila-pharmaceuticals-launches-iron-supplement-militol/

    EXPRESSPHARMA
    14 Nov 2024
    Share Share
    Ferric Maltol with Novell Process and Novell Polymorph
    Ferric Maltol with Novell Process and Novell Polymorph

    22 Aug 2022

    // PRESS RELEASE

    https://virujgroup.com/ferric-maltol/

    PRESS RELEASE
    22 Aug 2022
    Share Share
    UK drugmakers accused of illegal market sharing in supply of antibiotic
    UK drugmakers accused of illegal market sharing in supply of antibiotic

    25 Jul 2019

    // THE PHARMALETTER

    https://www.thepharmaletter.com/article/uk-drugmakers-accused-of-illegal-market-sharing-in-supply-of-antibiotic

    THE PHARMALETTER
    25 Jul 2019
    Share Share
    Norgine buys rights to sell Shield’s iron deficiency therapy
    Norgine buys rights to sell Shield’s iron deficiency therapy

    20 Sep 2018

    // Selina McKee PHARMA TIMES

    http://www.pharmatimes.com/news/norgine_buys_rights_to_sell_shields_iron_deficiency_therapy_1252801

    Selina McKee PHARMA TIMES
    20 Sep 2018
    Share Share